• MindSkipperBro12@lemmy.world
    link
    fedilink
    arrow-up
    5
    arrow-down
    30
    ·
    1 year ago

    Isn’t the catch that the funds for R&D for the advance kind of insulin extraordinarily expensive so that’s why the price is so ridiculously high?

    • Rom@lemm.ee
      link
      fedilink
      English
      arrow-up
      36
      ·
      1 year ago

      imo that doesn’t justify pricing people out of a drug that they will literally die without. It’s absolutely vile that the price of something essential for people to stay alive isn’t price controlled and is subject to the whims of the manufacturer.

    • Alto@kbin.social
      link
      fedilink
      arrow-up
      18
      arrow-down
      1
      ·
      1 year ago

      Considering the only reason they exist is so they can profit even more off of it, I don’t give a single fuck about their R&D expenses

      • jeremy@reddthat.com
        link
        fedilink
        arrow-up
        17
        ·
        1 year ago

        They haven’t changed this shit in 20 years. They’re just raking in cash like they’re Disney or something.

        Source: my daughter is 20 years old and has been using the same 3 rapid acting insulins the whole time. None of them have changed. ALL of them have gotten more expensive.

    • Meltbox@lemmy.world
      link
      fedilink
      arrow-up
      16
      arrow-down
      1
      ·
      1 year ago

      The one time congress actually did a case study on drug pricing they found that in all the internal discussions a drug company had while setting the price R&D costs were not mentioned even 1 single time.

      So it’s got nothing to do with profit.

    • theYogiB@lemmy.world
      link
      fedilink
      arrow-up
      10
      ·
      1 year ago

      Do you know how little of their own money pharma companies spend on R&D? The majority of their budget is for advertising and marketing. Most of their R&D budget is from government grants i.e. taxpayer money. Meaning more often than not you are paying twice for life-saving drugs.

    • Arakwar@kbin.social
      link
      fedilink
      arrow-up
      4
      ·
      1 year ago

      Unless they sell the new insulin at cost, then no, they don’t get to charge more for the existing product.

      They always say that they charge more to pay for the risk from R&D, but having people pay more an existing product to finance future R&D is the complete opposite of that.

      This is why some stuff should never be handled by private corporations.